| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACR Appropriateness Criteria Breast Cancer Screening
|
Sickles, E.A.
|
|
2013
|
24 |
3 |
p. 233-234
2 p.
|
artikel
|
| 2 |
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
|
Ross, J.S.
|
|
2013
|
24 |
3 |
p. 264-265
2 p.
|
artikel
|
| 3 |
American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns
|
Dengel, L.T.
|
|
2013
|
24 |
3 |
p. 256-257
2 p.
|
artikel
|
| 4 |
A Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation: First Report of Acute Toxicity, Feasibility, and Patient Satisfaction
|
Haffty, B.G.
|
|
2013
|
24 |
3 |
p. 274-275
2 p.
|
artikel
|
| 5 |
Assessing Radiologist Performance Using Combined Digital Mammography and Breast Tomosynthesis Compared with Digital Mammography Alone: Results of a Multicenter, Multireader Trial
|
Margolies, L.R.
|
|
2013
|
24 |
3 |
p. 237-238
2 p.
|
artikel
|
| 6 |
Axillary Dissection Versus No Axillary Dissection in Older Patients With T1N0 Breast Cancer: 15-Year Results of a Randomized Controlled Trial
|
Murphy, J.O.
|
|
2013
|
24 |
3 |
p. 251-253
3 p.
|
artikel
|
| 7 |
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors
|
Matrana, M.R.
|
|
2013
|
24 |
3 |
p. 224-225
2 p.
|
artikel
|
| 8 |
Breast Cancer: Assessing Response to Neoadjuvant Chemotherapy by Using US-guided Near-Infrared Tomography
|
Su, M.-Y.L.
|
|
2013
|
24 |
3 |
p. 239-241
3 p.
|
artikel
|
| 9 |
Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction
|
Takiar, V.
|
|
2013
|
24 |
3 |
p. 288-289
2 p.
|
artikel
|
| 10 |
Breast cancer survival in the US and Europe: a CONCORD high-resolution study
|
Hortobagyi, G.N.
|
|
2013
|
24 |
3 |
p. 223-
1 p.
|
artikel
|
| 11 |
Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons
|
Pilewskie, M.
|
|
2013
|
24 |
3 |
p. 261-262
2 p.
|
artikel
|
| 12 |
Characteristics and Outcomes of Sentinel Node–Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment
|
Winchester, D.J.
|
|
2013
|
24 |
3 |
p. 253-254
2 p.
|
artikel
|
| 13 |
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|
Barsan, V.
|
|
2013
|
24 |
3 |
p. 225-226
2 p.
|
artikel
|
| 14 |
Circulating microRNAs in plasma as early detection markers for breast cancer
|
Sun, Y.
|
|
2013
|
24 |
3 |
p. 241-242
2 p.
|
artikel
|
| 15 |
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
|
Russell, C.A.
|
|
2013
|
24 |
3 |
p. 283-284
2 p.
|
artikel
|
| 16 |
Computer-aided Detection of Masses at Mammography: Interactive Decision Support Versus Prompts
|
Nishikawa, R.M.
|
|
2013
|
24 |
3 |
p. 227-228
2 p.
|
artikel
|
| 17 |
Current Status of Implant-Based Breast Reconstruction in Patients Receiving Postmastectomy Radiation Therapy
|
Ho, A.
|
|
2013
|
24 |
3 |
p. 284-286
3 p.
|
artikel
|
| 18 |
Expression of cell adhesion molecules and prognosis in breast cancer
|
Gilcrease, M.Z.
|
|
2013
|
24 |
3 |
p. 247-248
2 p.
|
artikel
|
| 19 |
Frequency of Mesenchymal-Epithelial Transition Factor Gene (MET) and the Catalytic Subunit of Phosphoinositide-3-Kinase (PIK3CA) Copy Number Elevation and Correlation With Outcome in Patients With Early Stage Breast Cancer
|
Gilcrease, M.Z.
|
|
2013
|
24 |
3 |
p. 242-243
2 p.
|
artikel
|
| 20 |
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome
|
Gallardo, M.
|
|
2013
|
24 |
3 |
p. 243-245
3 p.
|
artikel
|
| 21 |
Impact of Internal Mammary Lymph Node Drainage Identified by Preoperative Lymphoscintigraphy on Outcomes in Patients With Stage I to III Breast Cancer
|
Bevilacqua, J.L.B.
|
|
2013
|
24 |
3 |
p. 229-
1 p.
|
artikel
|
| 22 |
Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population
|
Dengel, L.
|
|
2013
|
24 |
3 |
p. 254-256
3 p.
|
artikel
|
| 23 |
Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment
|
Robb, G.L.
|
|
2013
|
24 |
3 |
p. 286-288
3 p.
|
artikel
|
| 24 |
Long-term Changes in Pulmonary Function After Incidental Lung Irradiation for Breast Cancer: A Prospective Study With 7-Year Follow-up
|
Smith, B.D.
|
|
2013
|
24 |
3 |
p. 280-281
2 p.
|
artikel
|
| 25 |
Male Breast Cancer: Opportunities for Research and Clinical Trials
|
Bogler, Oliver
|
|
2013
|
24 |
3 |
p. 216-218
3 p.
|
artikel
|
| 26 |
Noninitiation of Adjuvant Chemotherapy in Women With Localized Breast Cancer: The Breast Cancer Quality of Care Study
|
Blinder, V.S.
|
|
2013
|
24 |
3 |
p. 265-267
3 p.
|
artikel
|
| 27 |
Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ
|
Moran, M.S.
|
|
2013
|
24 |
3 |
p. 249-251
3 p.
|
artikel
|
| 28 |
Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid
|
Shapiro, C.L.
|
|
2013
|
24 |
3 |
p. 220-221
2 p.
|
artikel
|
| 29 |
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
|
Glück, S.
|
|
2013
|
24 |
3 |
p. 281-282
2 p.
|
artikel
|
| 30 |
Patient Navigation for Breast and Colorectal Cancer in 3 Community Hospital Settings: An Economic Evaluation
|
Ballo, M.T.
|
|
2013
|
24 |
3 |
p. 219-
1 p.
|
artikel
|
| 31 |
Phase 1 Clinical Trial of Stereotactic Body Radiation Therapy Concomitant With Neoadjuvant Chemotherapy for Breast Cancer
|
Garg, A.K.
|
|
2013
|
24 |
3 |
p. 273-274
2 p.
|
artikel
|
| 32 |
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial
|
Kabos, P.
|
|
2013
|
24 |
3 |
p. 262-263
2 p.
|
artikel
|
| 33 |
Predictors of Locoregional Outcome in Patients Receiving Neoadjuvant Therapy and Postmastectomy Radiation
|
Huang, E.
|
|
2013
|
24 |
3 |
p. 275-276
2 p.
|
artikel
|
| 34 |
Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery
|
Hollingsworth, A.B.
|
|
2013
|
24 |
3 |
p. 230-233
4 p.
|
artikel
|
| 35 |
Prognostic Significance of the Number of Positive Lymph Nodes in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2, and 3 Positive Lymph Nodes Be Grouped Together?
|
Crew, J.
|
|
2013
|
24 |
3 |
p. 246-247
2 p.
|
artikel
|
| 36 |
Racial/Ethnic Disparities in Breast Cancer Risk: Genomics Meets Metabolomics
|
Chow, Wong-Ho
|
|
2013
|
24 |
3 |
p. 212-216
5 p.
|
artikel
|
| 37 |
Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter
|
Shaitelman, S.F.
|
|
2013
|
24 |
3 |
p. 278-279
2 p.
|
artikel
|
| 38 |
Reduced Incidence of Breast Cancer–Related Lymphedema following Mastectomy and Breast Reconstruction versus Mastectomy Alone
|
Mehrara, B.
|
|
2013
|
24 |
3 |
p. 259-260
2 p.
|
artikel
|
| 39 |
Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates
|
Mamounas, E.P.
|
|
2013
|
24 |
3 |
p. 257-259
3 p.
|
artikel
|
| 40 |
Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study
|
Day, S.
|
|
2013
|
24 |
3 |
p. 221-222
2 p.
|
artikel
|
| 41 |
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
|
Zibelman, M.
|
|
2013
|
24 |
3 |
p. 269-270
2 p.
|
artikel
|
| 42 |
The Addition of SPECT/CT Lymphoscintigraphy to Breast Cancer Radiation Planning Spares Lymph Nodes Critical for Arm Drainage
|
Freedman, G.M.
|
|
2013
|
24 |
3 |
p. 272-273
2 p.
|
artikel
|
| 43 |
The Adoption of New Adjuvant Radiation Therapy Modalities Among Medicare Beneficiaries With Breast Cancer: Clinical Correlates and Cost Implications
|
Recht, A.
|
|
2013
|
24 |
3 |
p. 276-278
3 p.
|
artikel
|
| 44 |
Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark
|
Kopans, D.B.
|
|
2013
|
24 |
3 |
p. 235-237
3 p.
|
artikel
|
| 45 |
Time to Adjuvant Chemotherapy for Breast Cancer in National Comprehensive Cancer Network Institutions
|
Lohrisch, C.A.
|
|
2013
|
24 |
3 |
p. 267-269
3 p.
|
artikel
|
| 46 |
Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ
|
Wagner, J.L.
|
|
2013
|
24 |
3 |
p. 248-249
2 p.
|
artikel
|
| 47 |
Unintended cardiac irradiation during left-sided breast cancer radiotherapy
|
Bloom, E.S.
|
|
2013
|
24 |
3 |
p. 271-
1 p.
|
artikel
|
Tijdschrift beschrijving